On the public citation graph
Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis
0 signed · 104 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.159.21.2562openalex-snapshot
Associations Between Initial Antimicrobial Therapy and Medical Outcomes for Hospitalized Elderly Patients With Pneumonia
inferredcites →https://doi.org/10.1001/jama.2015.3656openalex-snapshot
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data
inferredcites →https://doi.org/10.1001/jama.283.15.2008openalex-snapshot
Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting
inferredcites →https://doi.org/10.1001/jamainternmed.2014.4887openalex-snapshot
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
inferredcites →https://doi.org/10.1002/14651858.cd002109.pub4openalex-snapshot
Antibiotics for community-acquired pneumonia in adult outpatients
inferredcites →https://doi.org/10.1002/14651858.cd004418.pub3openalex-snapshot
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
inferredcites →https://doi.org/10.1002/14651858.mr000034.pub2openalex-snapshot
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials
inferredcites →https://doi.org/10.1007/s10096-005-1295-9openalex-snapshot
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone
inferredcites →https://doi.org/10.1007/s10096-006-0183-2openalex-snapshot
Addition of a macrolide to a ß-lactam in bacteremic pneumococcal pneumonia
inferredcites →https://doi.org/10.1038/srep14061openalex-snapshot
Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update
inferredcites →https://doi.org/10.1056/nejm199701233360402openalex-snapshot
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
inferredcites →https://doi.org/10.1056/nejmc1506892openalex-snapshot
Antibiotics for Community-Acquired Pneumonia in Adults
inferredcites →https://doi.org/10.1056/nejmoa1406330openalex-snapshot
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
inferredcites →https://doi.org/10.1086/367541openalex-snapshot
Addition of a Macrolide to a β‐Lactam–Based Empirical Antibiotic Regimen Is Associated with Lower In‐Hospital Mortality for Patients with Bacteremic Pneumococcal Pneumonia
inferredcites →https://doi.org/10.1086/511159openalex-snapshot
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
inferredcites →https://doi.org/10.1086/591404openalex-snapshot
Initial Antibiotic Selection and Patient Outcomes: Observations from the National Pneumonia Project
inferredcites →https://doi.org/10.1093/aje/kwm189openalex-snapshot
Should Meta-Analyses of Interventions Include Observational Studies in Addition to Randomized Controlled Trials? A Critical Examination of Underlying Principles
inferredcites →https://doi.org/10.1093/aje/kwp016openalex-snapshot
RE: "SHOULD META-ANALYSES OF INTERVENTIONS INCLUDE OBSERVATIONAL STUDIES IN ADDITION TO RANDOMIZED CONTROLLED TRIALS? A CRITICAL EXAMINATION OF UNDERLYING PRINCIPLES"
inferredcites →https://doi.org/10.1093/cid/cis414openalex-snapshot
Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1093/jac/dkp088openalex-snapshot
Impact of intravenous -lactam/macrolide versus -lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia
inferredcites →https://doi.org/10.1093/jac/dkr016openalex-snapshot
Comparative evaluation of synergy of combinations of -lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae
inferredcites →https://doi.org/10.1093/jac/dku033openalex-snapshot
β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1097/ccm.0b013e3182a66b9bopenalex-snapshot
Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia
inferredcites →https://doi.org/10.1111/j.1365-2796.2012.02554.xopenalex-snapshot
Treatment with anti‐inflammatory drugs in community‐acquired pneumonia
inferredcites →https://doi.org/10.1128/aac.43.12.3033openalex-snapshot
Beneficial Effect of Adjunctive Azithromycin in Treatment of Mucoid Pseudomonas aeruginosa Pneumonia in the Murine Model
inferredcites →https://doi.org/10.1128/aac.48.8.2787-2792.2004openalex-snapshot
Hazard Ratio in Clinical Trials
inferredcites →https://doi.org/10.1136/thorax.58.5.377openalex-snapshot
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
inferredcites →https://doi.org/10.1136/thoraxjnl-2012-202296openalex-snapshot
Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia: Table 1
inferredcites →https://doi.org/10.1136/thx.2006.069740openalex-snapshot
Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong
inferredcites →https://doi.org/10.1136/thx.2009.133280openalex-snapshot
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
inferredcites →https://doi.org/10.1155/2004/970828openalex-snapshot
Inpatient Care of Community‐Acquired Pneumonia: The Effect of Antimicrobial Guidelines on Clinical Outcomes and Drug Costs in Canadian Teaching Hospitals
inferredcites →https://doi.org/10.1164/rccm.200311-1578ocopenalex-snapshot
Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia
inferredcites →https://doi.org/10.1164/rccm.201501-0140ocopenalex-snapshot
Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort
inferredcites →https://doi.org/10.1183/09031936.00031007openalex-snapshot
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis
inferredcites →https://doi.org/10.1183/09031936.00054108openalex-snapshot
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
inferredcites →https://doi.org/10.1183/09031936.00092607openalex-snapshot
Can CAP guideline adherence improve patient outcome in internal medicine departments?
inferredcites →https://doi.org/10.1183/09031936.06.00126004openalex-snapshot
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
inferredcites →https://doi.org/10.1186/s12879-017-2495-5openalex-snapshot
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1378/chest.06-1426openalex-snapshot
Antibiotics for Bacteremic Pneumonia
inferredcites →https://doi.org/10.1378/chest.11-1908openalex-snapshot
Macrolide Antibiotics and Survival in Patients With Acute Lung Injury
inferredcites →https://doi.org/10.1378/chest.119.5.1420openalex-snapshot
Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western States
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4526511openalex-extracted
Clarithromycin for Early Anti-Inflammatory Responses in Community-Acquired Pneumonia: The ACCESS Randomized Trial
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.36230openalex-snapshot
Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions
inferred← citeshttps://doi.org/10.1007/s00228-024-03775-6openalex-snapshot
Effectiveness of macrolides as add-on therapy to beta-lactams in community-acquired pneumonia: A meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1007/s11606-024-08674-1openalex-snapshot
Identifying the Best Initial Oral Antibiotics for Adults with Community-Acquired Pneumonia: A Network Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s40121-021-00471-1openalex-snapshot
The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece
inferred← citeshttps://doi.org/10.1016/j.accpm.2021.100970openalex-snapshot
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients
inferred← citeshttps://doi.org/10.1016/j.arbr.2020.05.013openalex-snapshot
Dual Antibiotic Therapy for Outpatient Management of Community-acquired Pneumonia?
inferred← citeshttps://doi.org/10.1016/j.arbr.2020.06.007openalex-snapshot
Reply to “Dual antibiotic therapy for outpatient management of community-acquired pneumonia?”
inferred← citeshttps://doi.org/10.1016/j.arbres.2020.06.016openalex-snapshot
Respuesta a «Dual antibiotic therapy for outpatient management of community-acquired pneumonia?»
inferred← citeshttps://doi.org/10.1016/j.cmi.2017.06.013openalex-snapshot
Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV/AIDS: a randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.cmi.2025.06.033openalex-snapshot
Empiric antibiotic therapy for moderate-to-severe community-acquired pneumonia: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.idnow.2025.105034openalex-snapshot
Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French…
inferred← citeshttps://doi.org/10.1016/j.idnow.2025.105126openalex-snapshot
Antibiotic combination indications for the treatment of community-acquired acute pneumonia
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2019.10.017openalex-snapshot
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2023.106942openalex-snapshot
Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2024.107406openalex-snapshot
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial
inferred← citeshttps://doi.org/10.1016/j.jgar.2022.05.009openalex-snapshot
Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jinf.2017.03.005openalex-snapshot
Pneumolysin as a potential therapeutic target in severe pneumococcal disease
inferred← citeshttps://doi.org/10.1016/j.jiph.2025.102766openalex-snapshot
Association of fluoroquinolone resistance with rare quinolone resistance-determining region (QRDR) mutations and protein-quinolone binding affinity (PQBA) in multidrug-resistant Escherichia coli isolated from patients with urinary tract infection
inferred← citeshttps://doi.org/10.1016/j.jmii.2018.11.004openalex-snapshot
Recommendations and guidelines for the treatment of pneumonia in Taiwan
inferred← citeshttps://doi.org/10.1016/j.mmifmc.2025.01.065openalex-snapshot
Actualisation des recommandations de prise en charge des pneumonies aiguës communautaires chez l'adulte par la Société de Pathologie Infectieuse de Langue Française (SPILF) et la Société de Pneumologie de Langue Française (SPLF). Avec le soutien de la Société de Réanimation de Langue Française,…
inferred← citeshttps://doi.org/10.1016/j.resinv.2021.09.009openalex-snapshot
Atypical pneumonia: Pathophysiology, diagnosis, and treatment
inferred← citeshttps://doi.org/10.1016/j.resmer.2022.100931openalex-snapshot
Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.resmer.2025.101161openalex-snapshot
Update of guidelines for management of Community Acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF)
inferred← citeshttps://doi.org/10.1016/j.rmr.2025.01.003openalex-snapshot
Actualisation des recommandations de prise en charge des pneumonies aiguës communautaires chez l’adulte par la Société de pathologie infectieuse de langue française (SPILF) et la Société de pneumologie de langue française (SPLF). Avec le soutien de la Société de réanimation de langue française,…
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)00630-9openalex-snapshot
Community-acquired pneumonia
inferred← citeshttps://doi.org/10.1016/s1877-1203(21)00064-1openalex-snapshot
Bonne utilisation des antibiotiques : du diagnostic à l’arrêt du traitement
inferred← citeshttps://doi.org/10.1016/s2213-2600(23)00412-5openalex-snapshot
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1038/s41598-019-54922-4openalex-snapshot
Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis
inferred← citeshttps://doi.org/10.1038/s41598-025-27245-wopenalex-snapshot
Impact of macrolide therapy on clinical outcomes in hospitalized pneumonia patients: a retrospective study from Lebanese hospitals
inferred← citeshttps://doi.org/10.1039/d1tb01770eopenalex-snapshot
Nanomedicine to advance the treatment of bacteria-induced acute lung injury
inferred← citeshttps://doi.org/10.1080/14656566.2019.1589451openalex-snapshot
Pharmacological management of sepsis in adults with a focus on the current gold standard treatments and promising adjunctive strategies: evidence from the last five years
inferred← citeshttps://doi.org/10.1080/14787210.2021.1834848openalex-snapshot
Role of the inflammatory response in community-acquired pneumonia: clinical implications
inferred← citeshttps://doi.org/10.1093/ofid/ofag253openalex-snapshot
Beta-Lactam Plus Azithromycin or Doxycycline vs Fluoroquinolones in Adult Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Network Meta-analysis
inferred← citeshttps://doi.org/10.1097/ec9.0000000000000106openalex-snapshot
Efficacy and safety of clarithromycin for patients with sepsis or septic shock: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1111/resp.13016openalex-snapshot
Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology
inferred← citeshttps://doi.org/10.1111/resp.13232openalex-snapshot
Mortality in patients with community‐onset pneumonia at low risk of drug‐resistant pathogens: Impact of β‐lactam plus macrolide combination therapy
inferred← citeshttps://doi.org/10.11606/t.5.2018.tde-28032018-125159openalex-snapshot
Ensaio clínico randomizado sobre o impacto dos macrolídeos na mortalidade de pacientes infectados pelo HIV e com pneumonia adquirida na comunidade
inferred← citeshttps://doi.org/10.1164/rccm.201908-1581stopenalex-snapshot
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
inferred← citeshttps://doi.org/10.1177/02676591241297401openalex-snapshot
Interaction of azithromycin and methylprednisolone with ex-vivo extracorporeal membrane oxygenation circuits (ECMO)
inferred← citeshttps://doi.org/10.1183/20734735.0190-2025openalex-snapshot
The use of macrolides in the treatment of community-acquired pneumonia: risks and benefits
inferred← citeshttps://doi.org/10.1186/s12879-017-2495-5openalex-snapshot
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12879-025-12408-xopenalex-snapshot
Beta-lactam plus macrolide treatment versus beta-lactam monotherapy for community-acquired pneumonia: a propensity score analysis using data from a multicenter prospective cohort study
inferred← citeshttps://doi.org/10.12688/f1000research.14226.1openalex-snapshot
Appropriate antibiotic management of bacterial lower respiratory tract infections
inferred← citeshttps://doi.org/10.12968/hmed.2019.0348openalex-snapshot
When are combinations of antibiotics clinically useful?
inferred← citeshttps://doi.org/10.15446/revfacmed.v70n2.93814openalex-snapshot
Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
inferred← citeshttps://doi.org/10.18093/0869-0189-2022-32-3-295-355openalex-snapshot
Federal guidelines on diagnosis and treatment of community-acquired pneumonia
inferred← citeshttps://doi.org/10.2147/idr.s302852openalex-snapshot
Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
inferred← citeshttps://doi.org/10.2147/rmhp.s317735openalex-snapshot
Deep Learning-Based Available and Common Clinical-Related Feature Variables Robustly Predict Survival in Community-Acquired Pneumonia
inferred← citeshttps://doi.org/10.24557/kokyurinsho.1.e00006openalex-snapshot
【特集】「成人肺炎診療ガイドライン2017」を読み解く 市中肺炎
inferred← citeshttps://doi.org/10.25077/jsfk.6.2.147-157.2019openalex-snapshot
Analisa Perbandingan Monoterapi dengan Dualterapi Antibiotik Empiris terhadap Outcome pada Pasien Community Acquired Pneumonia (CAP) di IGD RSUP Fatmawati Jakarta
inferred← citeshttps://doi.org/10.30629/0023-2149-2023-101-11-212-229openalex-snapshot
Diagnosis and treatment of community-acquired pneumonia in military personnel (Guidelines)
inferred← citeshttps://doi.org/10.32687/0869-866x-2022-30-s1-1044-1049openalex-snapshot
FEATURES OF THE USE OF ANTIBACTERIAL DRUGS IN PATIENTS WITH COVID-19
inferred← citeshttps://doi.org/10.3389/fneur.2019.00504openalex-snapshot
Antibiotic Class and Outcome in Post-stroke Infections: An Individual Participant Data Pooled Analysis of VISTA-Acute
inferred← citeshttps://doi.org/10.3389/fphar.2021.680178openalex-snapshot
Antibiotic Treatment of Pulmonary Infections: An Umbrella Review and Evidence Map
inferred← citeshttps://doi.org/10.3390/v15051142openalex-snapshot
Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database
inferred← citeshttps://doi.org/10.36488/cmac.2019.1.27-38openalex-snapshot
Antibiotics and community-acquired lower respiratory tract infections. To whom? Which one?
inferred← citeshttps://doi.org/10.4067/s0717-73482023000100060openalex-snapshot
VI. Tratamiento de la neumonía del adulto adquirida en la comunidad
inferred← citeshttps://doi.org/10.70675/ac457573zaaa0z4d4fz8d0ez998e270140f5openalex-snapshot
Durée de traitement des pneumonies aigues communautaires modérément sévères
inferred← citeshttps://doi.org/10.70675/ecaa782bz76f7z4c43za043ze1d3e0cfbfaaopenalex-snapshot
Contribution des études observationnelles dans la méta-analyse
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.